CD8A and neoplasm: In addition, treatment with XRT+αCTLA4+αPD1 resulted in a significant increase in the percentage of CD4+ T cells (as well as a trend to Treg increase) and a concomitant decrease in the percentage of CD8+ T cells and NK cells within the secondary tumor.